Van Bever H P, Stevens W J
Dept of Paediatrics, University of Antwerp, Belgium.
Eur Respir J. 1992 Mar;5(3):318-22.
The effect of hyposensitization (HS) upon the allergen evoked immediate asthmatic reaction (IAR), late asthmatic reaction (LAR) and upon bronchial reactivity towards histamine was examined. Eighteen young asthmatic patients were studied using a double-blind, placebo-controlled design. All were allergic to house dust mite (HDM) and demonstrated an IAR and a LAR after bronchial provocation with HDM. Furthermore, all, except one child, demonstrated bronchial hyperreactivity towards histamine (median provocative dose producing a 20% fall in forced expiratory volume in one second (PD20) histamine = 0.19 mg.ml-1, range: 0.02-8 mg.ml-1). The subjects were randomly divided into two groups to receive HDM or placebo injections during one year. After the one year period, the IAR was less severe in the subjects who received HDM injections (p = 0.02), while this reduction was not observed in the subjects who received placebo injections. Also, in the HDM group a small but significant increase of the median PD20 HDM was observed (p = 0.04). Furthermore, the LAR was less severe in the subjects who received HDM injections (p = 0.02), while the subjects who received placebo injections showed the same severity of LAR after one year (p = 0.44). Histamine reactivity did not change after HDM injections or after placebo injections. Thus, HS reduces the severity of the IAR and LAR without any change in histamine reactivity.
研究了减敏疗法(HS)对变应原诱发的速发型哮喘反应(IAR)、迟发型哮喘反应(LAR)以及支气管对组胺反应性的影响。采用双盲、安慰剂对照设计对18名年轻哮喘患者进行了研究。所有患者均对屋尘螨(HDM)过敏,且在HDM支气管激发试验后出现IAR和LAR。此外,除一名儿童外,所有患者均表现出对组胺的支气管高反应性(使一秒用力呼气量下降20%的组胺激发剂量中位数(PD20组胺)=0.19mg/ml,范围:0.02 - 8mg/ml)。受试者被随机分为两组,在一年时间内接受HDM或安慰剂注射。一年后,接受HDM注射的受试者IAR症状较轻(p = 0.02),而接受安慰剂注射的受试者未观察到这种减轻。此外,在HDM组中观察到PD20 HDM中位数有小幅但显著增加(p = 0.04)。此外,接受HDM注射的受试者LAR症状较轻(p = 0.02),而接受安慰剂注射的受试者一年后LAR严重程度相同(p = 0.44)。HDM注射或安慰剂注射后组胺反应性未发生变化。因此,HS可减轻IAR和LAR的严重程度,而组胺反应性无任何改变。